מדינה: ישראל
שפה: אנגלית
מקור: Ministry of Health
RANITIDINE AS HYDROCHLORIDE
DEXCEL LTD, ISRAEL
A02BA02
TABLETS
RANITIDINE AS HYDROCHLORIDE 150 MG
PER OS
Required
DEXCEL LTD, ISRAEL
RANITIDINE
RANITIDINE
Adults:ZARIDEX is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. Zaridex is also indicated for the treatment of post-operative ulcer, Zollinger-Ellison Syndrome and oesophageal reflux disease including long term management of healed oesophagitis. ZARIDEX is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's Syndrome), particularly obstetric patients during labour. Children (6 to 18 years):Short term treatment of peptic ulcer. Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.
2013-01-31
_ _ ילוי 1029 ZARIDEX 150, TABLETS ZARIDEX 300, CAPLETS ,דבכנ יאופר תווצ לסקד תרבח מ"עב תשקבמ םכעידוהל ןוכדע לע ב ולע ן אפורל לש רישכתה םי : סקדירז 250 , 000 . העדוהב וז םינוכדעה םיטרופמ יתוחיטבה עדימב הרמחה םיווהמה .דבלב ולעב ןייעל שי ,אלמ עדימל ן . ולעה ן ורל אפ תואירבה דרשמ רתאבש תופורתה רגאמב םוסרפל חלשנ לבקל ןתינו ספדומ ו היינפ י"ע לסקד :םושירה לעבל לסקד 'חר ,מ"עב 1 רוא , אביקע 0363333 :'לט ,לארשי , 30-6060333 . בכרה רישכתה : ZARIDEX 150: Each tablet contains ranitidine 150 mg (as hydrochloride). ZARIDEX 300: Each caplet contains ranitidine 300 mg (as hydrochloride). יוותה תו רשואמ ו :ת Adults: Zaridex is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. Zaridex is also indicated for the treatment of post-operative ulcer, Zollinger-Ellison Syndrome and oesophageal reflux disease including long term management of healed oesophagitis. Zaridex is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's Syndrome), particularly obstetric patients during labour. Children (6 to 18 years): Short term treatment of peptic ulcer. Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease. ןולעה ל אפור כדוע ן ב ךיראת ינוי 1029 . ןלהל םינוכדעה יתוחיטבה עדימב הרמחה םיווהמה ( םינמוסמ ב םודא ) : 4. CLINICAL PARTICULARS ]...[ 4.8 UNDESIRABLE EFFECTS ]...[ IMMUNE SYSTEM DISORDE קרא את המסמך השלם
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT ZARIDEX 150, tablets ZARIDEX 300, caplets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ZARIDEX 150 mg: Each tablet contains ranitidine 150 mg (as hydrochloride). Excipients with known effect: Each tablet contains approximately 4 mg lactose. Each tablet contains approximately 1.1 mg sodium. ZARIDEX 300 mg: Each caplet contains ranitidine 300 mg (as hydrochloride). Excipients with known effect: Each caplet contains approximately 7 mg lactose. Each tablet contains approximately 2.2 mg sodium. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM 150 mg tablet, 300 mg caplet. ZARIDEX 150: Yellow, round, film-coated tablets. ZARIDEX 300: Yellow, film-coated caplets scored on one side. The score line is not intended for breaking the caplet. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Adults: Zaridex is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. Zaridex is also indicated for the treatment of post-operative ulcer, Zollinger- Ellison Syndrome and oesophageal reflux disease including long term management of healed oesophagitis. Zaridex is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's Syndrome), particularly obstetric patients during labour. Children (6 to 18 years): Short term treatment of peptic ulcer. Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults (including the elderly) The usual dosage is 150 mg twice daily, taken in the morning and evening. Alternatively, patients with duodenal ulceration, gastric ulceration or oesophageal refl קרא את המסמך השלם